EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 9 November 2017

News

09112017 EFPIA survey underlines the importance of action on medicines to prevent patients...
09 November 2017

The survey highlighted that medicines used by patients across Europe have integrated supply chains, which include the... Read more

Events

09112017 FEAM European Biomedical Policy Forum workshop on “Use of data in cross-border biomedical...
20 November 2017 (Brussels)

A FEAM European Biomedical Policy Forum workshop Read more

19 July 2017 War on Cancer – a patient’s journey
21 November 2017 (The HAC, London, UK)

3rd annual conference organised by The Economist Events Read more

Documents

Assessing the impact of proposals for a Supplementary Protection Certificate (SPC) Manufacturing...
27 October 2017 (Publications)

A study by QuintilesIMS Read more

Health Collaboration Guide 2017
26 October 2017 (Publications)

Showcasing best practice collaborations between patient organisations and industry, but also local authorities, governments,... Read more

Working together with patient groups
11 October 2017 (Publications)

A publication from the Patient Think Tank to provide guidance for collaboration Read more

What we are reading

Stop using antibiotics in healthy animals to prevent the spread of antibiotic resistance
On 07 November 2017 (WHO)

WHO is recommending that farmers and the food industry stop using antibiotics routinely to promote growth and prevent... Read more

Help wanted in the fight against AMR: World Pharma Association wants to see incentives – but...
On 06 November 2017 (IFPMA)

Antibiotics resistance is a global problem. At the World Health Summit 2017 in Berlin experts issued an urgent call... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu